How to Choose a Software Development Partner for Your Healthtech Startup

The best software development company for a healthcare startup is one that treats compliance as an architecture problem, and can prove it. Concretely, that means a partner who scopes HIPAA into the build from the first document, signs a business associate agreement when they'll touch protected health information, vets every third-party vendor in the chain, and prices the compliance work as visible line items instead of burying it. General vetting criteria still matter (track record, process, ownership terms), but in healthtech the compliance criteria come first, because a partner who gets those wrong can sink the company, and this guide covers how to test for both.

Why healthtech vendor selection is different

Most software mistakes cost money. Healthtech mistakes can cost the business itself: a privacy violation, a torpedoed enterprise deal, a product that has to be rebuilt before a hospital's security team will look at it twice. The uncomfortable part is that a non-compliant build and a compliant one look identical in a demo. The differences live in the data model, the access controls, the logging, and the vendor contracts, none of which show up on a screen.

That's why the standard agency-vetting playbook isn't enough on its own. You're choosing someone to make dozens of invisible decisions correctly, months before any auditor, customer, or regulator checks the work. We've written a full primer on what actually makes software HIPAA-compliant. This guide is the companion question: how to find a partner who'll build it that way.

There's also a timing asymmetry worth naming. The cost gap between compliant and non-compliant architecture is small at design time (mostly decisions, not effort) and enormous after launch, when a retrofit touches every endpoint and table on a product already serving users. Vendor selection is the one moment you fully control that timing. The partner you pick either spends those cheap early decisions well or commits you to the expensive version later, which is why this choice deserves more diligence than any feature on the roadmap.

The healthtech-specific criteria

Five checks, in the order they tend to disqualify vendors.

• They raise HIPAA before you do. If patient data is anywhere near your product and the partner's proposal doesn't mention PHI, BAAs, or safeguards, that's the whole answer. Compliance retrofits are expensive precisely because the cheap version happens at architecture time.
• They'll sign a BAA, and they know when one is needed. A development partner who will access PHI (in production support, in debugging, in data migration) is a business associate under HIPAA and needs to sign an agreement saying so. Watch for the partner who explains when a BAA is and isn't required; that fluency is hard to fake.
• They vet the whole vendor chain. Your product will sit on hosting, analytics, messaging, and probably AI services. Every vendor that touches PHI needs its own BAA, and one convenient tool without one breaks the chain. Ask a candidate how they'd evaluate adding an AI feature to a patient-facing product, and listen for vendor vetting before model choice.
• They can walk you through a security questionnaire. Enterprise health customers send them, and the questions are specific: where data lives, who can access it, how access is logged, how incidents get reported. A partner who has answered these before will say so with examples. A partner who hasn't will find out on your deal.
• They separate compliant architecture from compliance theater. There is no official HIPAA certification for software. A vendor selling a "HIPAA certificate" is selling marketing. What exists is compliant architecture, documented safeguards, and contracts, and a serious partner says exactly that.

The general criteria still apply

Compliance fluency doesn't excuse a partner from the ordinary tests. You still want a firm that shows you shipped products, scopes on paper before quoting, prices in line items, and hands you the code, the repositories, and the accounts. Our guide to choosing a software development partner walks through those criteria in full, including the questions that expose who actually writes the code. Run both lists. A healthtech partner has to pass the ordinary bar and the regulated one.

One criterion earns extra weight in healthtech: a single team covering strategy, design, and engineering. Compliance decisions cut across all three (what data a screen collects is a design decision, where it's stored is an engineering one, whether it's needed at all is strategy), and handoffs between separate firms are where PHI handling falls through the cracks.

Questions to ask before you sign

Put these in writing and keep the answers.

• Will you sign a BAA, and in which parts of this engagement do you expect to access PHI?
• Which parts of the proposed stack will touch PHI, and does each vendor on that list offer a BAA?
• How do you keep PHI out of development and testing environments?
• What does compliance add to this build, as line items we can see?
• Which past clients' products have been through a customer security review, and what came out of it?
• Who owns the code, the infrastructure accounts, and the documentation when we part ways?

Vague answers to specific questions are answers. A partner worth hiring will treat this list as normal diligence, and the interview itself becomes evidence of how they'll handle the build.

Keep the results. The written answers become part of your compliance story later: when an enterprise customer's security review asks how vendors were selected, a documented diligence process is itself evidence that the company takes PHI seriously.

Red flags that should end the conversation

Some signals are worth walking away from without a second meeting.

• A "HIPAA certified" badge. No such certification exists for software, so the badge tells you the vendor either doesn't know that or hopes you don't.
• Compliance as a line to add later. Any version of "we'll build it fast, then harden it for HIPAA once you have traction" is a plan to build large parts of the product twice, at your expense.
• Flat refusal to sign a BAA for work that touches PHI. Reasonable partners negotiate scope and responsibilities. A partner who won't put their obligations in writing is telling you how support tickets will go later.
• Real patient data in the demo environment. If a vendor shows you a staging system with what looks like live PHI in it, that's how they'll treat yours.
• A quote with no compliance line items. Encryption, audit logging, access controls, and vendor vetting are real work. When they don't appear in the price, they usually don't appear in the build.

How AI features change the vetting

Most healthtech roadmaps now include an AI feature: intake summarization, chart search, a patient-facing assistant. That's where otherwise compliant products quietly become liabilities, because the convenient way to add AI is to send data to a third-party model vendor, and PHI can't go anywhere a BAA doesn't cover. When you're vetting a partner, put an AI feature on the table and watch the order of their answer. The right order starts with which vendors offer BAAs, what data the feature genuinely needs, and how to keep identifiers out of prompts, and only then gets to model quality. Our HIPAA primer covers the underlying mechanics; in a vendor interview, the point is simpler. A partner who leads with the model has already made the mistake you're paying them to prevent.

What this looks like in a scoped engagement

Here's how we structure it. Every build starts with a Discovery: a fixed price process, 2 to 3 weeks, kickoff 7 to 10 business days after signing. For a healthtech product, that's where compliance enters the plan: the requirements document covers how PHI moves through the system, the API recommendations account for which vendors offer BAAs, and the line-item pricing makes the compliance work visible instead of vanishing into a day rate. You leave with deliverables you can hand to any team, which also makes Discovery a low-risk way to pressure-test us against the criteria above. We've delivered 100+ products since 2017, the code is yours from day one, and we take on fewer projects so we can do each one well.

Building something patient data will flow through? A fixed price Discovery scopes the product and the compliance architecture together, and ends with line-item pricing whoever you build with. Book a Discovery or get in touch and tell us what you're building.

Written by Jeremy - COO at Iron Forge Development, a U.S.-based software commercialization firm that has helped launch 100+ products from idea to market.